Actinium Pharmaceuticals Inc (ATNM)

9.75 -0.10 (-1.02%) USD  |  NYAM  |  May 17, 16:00
9.75 0.00 (0.00%) After-Hours: 20:00
More

Actinium Pharmaceuticals Current Deferred Liabilities (Quarterly)

Current Deferred Liabilities (Quarterly) Chart

View Current Deferred Liabilities (Quarterly) for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Current Deferred Liabilities (Quarterly) Data

View and export this data back to 2021. Upgrade now.
Date Value
September 30, 2022 --
June 30, 2022 --
Date Value
March 31, 2022 --
December 31, 2021 --

Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Upgrade
Minimum
Sep 2022
Upgrade
Maximum
Dec 2021
Upgrade
Average
Upgrade
Median
Jun 2022

Current Deferred Liabilities (Quarterly) Benchmarks

Perspective Therapeutics Inc --
Eli Lilly and Co --
Cellectar Biosciences Inc --
Outlook Therapeutics Inc --
Bristol-Myers Squibb Co --